本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Recursion Pharmaceuticals, Inc.

5.32
-0.5900-9.98%
盤後5.320.00000.00%16:16 EDT
成交量:5,757.08萬
成交額:3.24億
市值:23.10億
市盈率:-2.95
高:6.20
開:6.04
低:5.30
收:5.91
52周最高:12.36
52周最低:3.79
股本:4.34億
流通股本:4.15億
量比:1.09
換手率:13.87%
股息:- -
股息率:- -
每股收益(TTM):-1.8042
每股收益(LYR):-1.6909
淨資產收益率:-86.34%
總資產收益率:-39.08%
市淨率:2.51
市盈率(LYR):-3.15

資料載入中...

2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/20

重要事件披露

Form 8-K - Current report
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/04

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/18

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities